noscript

News and Announcements

MedAdvisor International Pty Ltd (ASX:MDR) Annual Update 2015; Lists on the ASX & Establishes Important Partnerships

  • Published January 05, 2016 2:53PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

2015 Highlights:

  • Raises $5m in oversubscribed public offer
  • Commences trading on the ASX under ticker code MDR
  • Announces new medication training relationship with Amgen
  • Share price up 90% since listing
  • Established important partnerships with pharmaceutical companies GSK, UCB, AstraZeneca and Apotex, as well as private health insurer, BUPA
  • One quarter of Australian pharmacies subscribed to the MedAdvisor platform

ABOUT MEDADVISOR INTERNATIONAL:

MedAdvisor International Pty Ltd is an Australian medical technology business focused on designing and commercialising world class software platforms for medication management on mobile and internet devices. MedAdvisor’s Platform connects to pharmacy dispensing systems, automatically retrieving medication records and driving an intelligent training, information and reminder system to ensure correct and reliable medication use.

MedAdvisor has established strategic partnerships with Bupa Australia and most recently, distribution partner Apotex Australia. The company is also supported by Australia’s major pharmacies including Amcal, Chemmart, Terry White Chemists, Guardian Pharmacy and more.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now